CPX-351
Vyxeos
Filters
Save & Share
Clear Filters
Location
Explore options near your center - or near your patient's home.
Diagnosis
Purpose of Trial
Filter and find trials based on their purpose.
Risk Level
Enter this patient's risk level (IPSS-R / IPSS-M).
Near Add Your Location
Accepting patients
CPX-351 (VYXEOS)
A Prospective, Single Site, Single-Arm Pilot Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms
Learn more- Allogeneic Stem Cell Transplant
- Chemotherapy
- Steroid
- Phase 2
Accepting patients
CPX-351 Plus Quizartinib
A Phase I/II Study of Liposomal Cytarabine and Daunorubicin (CPX-351) in Combination With Quizartinib in Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
Learn more- Tyrosine Kinase (TK) Inhibitor
- Phase 1/2
Accepting patients
CPX-351
Phase 1 Dose Escalation Study of CPX-351 for Patients With Int-2 or High Risk IPSS Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia After Failure to Hypomethylating Agents
Learn more- Chemotherapy
- Phase 1
Accepting patients
CPX-351 Plus Gemtuzumab Ozogamicin
A Pilot Study of Liposomal Cytarabine and Daunorubicin (CPX-351) in Combination With Gemtuzumab Ozogamicin (GO) in Relapsed Refractory Patients With Acute Myeloid Leukemia (AML) and Post-Hypomethylating Agent (Post-HMA) Failure High-Risk Myelodysplastic Syndrome (HR-MDS)
Learn more- Antibody Drug Conjugate (ADC)
- Phase 2
- Has results
Accepting patients
CPX-351 Plus Ivosidenib
Phase II Investigator Sponsored Study of CPX-351 in Combination With Ivosidenib for Patients With IDH1 Mutated Acute Myeloid Leukemia or High-Risk MDS
Learn more- IDH1 Inhibitor
- Phase 2